Literature DB >> 10989635

Possible association of active gastritis, featuring accelerated cell turnover and p53 overexpression, with cancer development at anastomoses after gastrojejunostomy. Comparison with gastroduodenostomy.

H Tanigawa1, H Uesugi, H Mitomi, K Saigenji, I Okayasu.   

Abstract

To cast light on tumorigenesis in the remnant stomach after distal gastrectomy for peptic ulcer or gastric cancer, 45 cases in gastroduodenostomy (Billroth I, 17 cases) and gastrojejunostomy (Billroth II, 28 cases) groups were compared for a series of parameters. Cancers in Billroth II were significantly more predominant in the anastomosis area and more frequently associated with Epstein-Barr virus infection. Active gastritis, accelerated epithelial cell turnover (as assessed by measurements of apoptosis and cell proliferation), DNA damage, and foveolar cell hyperplasia were all greater in anastomotic areas after Billroth II than in proximal areas after Billroth II or either area after Billroth I. K-ras mutations were rare, but Epstein-Barr virus infection in cancers was seen frequently in anastomosis cases. In conclusion, active gastritis, possibly induced by enterogastric reflux, is linked to tumorigenesis in anastomosis sites in Billroth II cases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10989635     DOI: 10.1093/ajcp/114.3.354

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

1.  Roux-en-Y hepaticojejunostomy or hepaticoduodenostomy for biliary reconstruction during the surgical treatment of choledochal cyst: which is better?

Authors:  Akihiro Shimotakahara; Atsuyuki Yamataka; Toshihiro Yanai; Hiroyuki Kobayashi; Tadaharu Okazaki; Geoffrey J Lane; Takeshi Miyano
Journal:  Pediatr Surg Int       Date:  2005-01       Impact factor: 1.827

Review 2.  Role of laparoscopy in treatment of choledochal cysts in children.

Authors:  Mei Diao; Long Li; Wei Cheng
Journal:  Pediatr Surg Int       Date:  2013-01-31       Impact factor: 1.827

3.  Epstein-Barr virus-associated gastric carcinoma in the remnant stomach: de novo and metachronous gastric remnant carcinoma.

Authors:  Yasuharu Kaizaki; Osamu Hosokawa; Shinji Sakurai; Masashi Fukayama
Journal:  J Gastroenterol       Date:  2005-06       Impact factor: 7.527

Review 4.  Gastric cancer arising from the remnant stomach after distal gastrectomy: a review.

Authors:  Shinsuke Takeno; Tatsuya Hashimoto; Kenji Maki; Ryosuke Shibata; Hironari Shiwaku; Ippei Yamana; Risako Yamashita; Yuichi Yamashita
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

5.  Epstein-Barr virus infection and genome polymorphisms on gastric remnant carcinoma: a meta-analysis.

Authors:  Chao Lu; Hongtao Zhang; Weihua Zhou; Xingyong Wan; Lan Li; Chaohui Yu
Journal:  Cancer Cell Int       Date:  2020-08-18       Impact factor: 5.722

6.  Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location.

Authors:  Gwen Murphy; Ruth Pfeiffer; M Constanza Camargo; Charles S Rabkin
Journal:  Gastroenterology       Date:  2009-05-13       Impact factor: 22.682

7.  Frequent loss of RUNX3 gene expression in remnant stomach cancer and adjacent mucosa with special reference to topography.

Authors:  Y Nakase; C Sakakura; K Miyagawa; S Kin; K Fukuda; A Yanagisawa; K Koide; N Morofuji; Y Hosokawa; K Shimomura; K Katsura; A Hagiwara; H Yamagishi; K Ito; Y Ito
Journal:  Br J Cancer       Date:  2005-02-14       Impact factor: 7.640

8.  Gastric mixed adenoneuroendocrine carcinoma occurring 50 years after a gastroenterostomy with braun anastomosis.

Authors:  Hiroshi Nemoto; Genshu Tate; Kazuaki Yokomizo; Takahiro Umemoto; Taketo Matsubara; Hiroki Mizukami; Gaku Kigawa; Akihiko Matsumiya; Junichi Tanaka
Journal:  Case Rep Oncol       Date:  2014-05-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.